Avid Bioservices Inc (CDMO)

[biopharm]

Janney Healthcare Analysts

Roy Buchanan, Ph.D.
Vice President, Biotechnology
212-940-6985

Debjit Chattopadhyay, Ph.D.
Managing Director, Biotechnology
215-665-6224

Paul Knight, CFA
Managing Director, Head of Healthcare Research
212-888-2696

Ken Trbovich, CFA
Director, Specialty Pharmaceuticals
215-665-6290

http://www.janney.com/institutions--corporations/equities/equity-research/our-team

.... looks like Cantor Fitzgerald's Mara Goldstein is fully aware of PS Targeting potential, as she shows up with George Z. and Joe Pantginis

https://www.linkedin.com/in/mara-goldstein-11503a11
http://www.thelifesciencesreport.com/pub/na/the-small-cap-biotech-watchlist-2015-unwrapped-who-are-these-guys-and-why-are-they-here

Chiara Russo (ex-Janney) shows up over at Cantor Fitzgerald as well

https://www.linkedin.com/in/chiara-russo-4a05165

just tossing some puzzle pieces out here.... guess I'm curious about the new top 3 increase by the time mid Feb 2016 comes along

We should have all 4 analysts, increasing price targets, within 30 days of the conference call